BIOMERICA INC. - COMMON STOCK
0.6000
02-5月-24 15:59:06
15 分の遅延
株式
-0.0301
-4.78%
本日の幅
0.5922 - 0.6301
ISIN
N/A
ソース
NASDAQ
-
08 3 2023 08:19:00 提供 Nasdaq GlobeNewswire
-
Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock
07 3 2023 16:39:57 提供 Nasdaq GlobeNewswire
-
Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock
03 3 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Biomerica Announces Proposed Underwritten Public Offering of Common Stock
02 3 2023 17:15:01 提供 Nasdaq GlobeNewswire
-
Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022
13 1 2023 18:39:00 提供 Nasdaq GlobeNewswire
-
10 1 2023 08:19:00 提供 Nasdaq GlobeNewswire
-
08 12 2022 08:19:00 提供 Nasdaq GlobeNewswire
-
02 11 2022 08:19:00 提供 Nasdaq GlobeNewswire
-
14 10 2022 09:18:00 提供 Nasdaq GlobeNewswire
-
Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
13 10 2022 16:50:00 提供 Nasdaq GlobeNewswire
-
29 9 2022 08:19:00 提供 Nasdaq GlobeNewswire
-
Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer
30 8 2022 08:19:00 提供 Nasdaq GlobeNewswire
-
Biomerica Reports Fiscal 2022 Year End Results
29 8 2022 16:41:00 提供 Nasdaq GlobeNewswire
-
Walmart to Begin Selling Biomerica’s Aware® Breast Self Exam
14 7 2022 08:19:00 提供 Nasdaq GlobeNewswire
-
Biomerica to Participate at BTIG Biotech Conference
23 6 2022 08:19:00 提供 Nasdaq GlobeNewswire
-
Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™
12 5 2022 08:19:00 提供 Nasdaq GlobeNewswire
-
26 4 2022 08:19:00 提供 Nasdaq GlobeNewswire
-
Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021
14 4 2022 08:37:00 提供 Nasdaq GlobeNewswire
-
08 2 2022 06:39:00 提供 Nasdaq GlobeNewswire
-
Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
13 1 2022 08:19:00 提供 Nasdaq GlobeNewswire